EGF R antibody | G02-2D5
Mouse anti Human EGF Receptor, clone G02-2D5 recognizes the epidermal growth factor (EGF) receptor, a 150 kDa transmembrane receptor also known as ERBB1. The EGF receptor is a member of the ERBB family of four structurally related receptor tyrosine kinases. Binding of one of the many EGF receptor ligands (EGF, amphiregulin, TGFα, epiregulin) causes homodimerization of the receptor. This leads to downstream activation of several signalling pathways including MAPK/ERK, PI3K/Akt and PLCγ/PKC (Prenzel et al. 2001).
Overexpression of the EGF receptor promotes gene amplification and mutation consequence in cell proliferation, survival, invasion, metastasis, and tumor induced neoangiogenesis (Ciardiello & Tortora, 2008).
Overexpression of the EGF receptor promotes gene amplification and mutation consequence in cell proliferation, survival, invasion, metastasis, and tumor induced neoangiogenesis (Ciardiello & Tortora, 2008).
Product Details
- Target Species
- Human
- Product Form
- Purified IgG - liquid
- Preparation
- Purified IgG prepared by affinity chromatography on Protein G from ascites
- Buffer Solution
- Phosphate buffered saline
- Preservative Stabilisers
- 0.09% Sodium Azide (NaN3)
- Immunogen
- E. coli derived recombinant protein corresponding to aa 363-499 of the human EGF receptor
- Approx. Protein Concentrations
- IgG concentration 1.0 mg/ml
- Fusion Partners
- Spleen cells from immunised BALB/c mice were fused with cells of the mouse SP2/0 myeloma cell line.
Storage Information
- Storage
- Store at +4oC or at -20oC if preferred.
Storage in frost-free freezers is not recommended.
This product should be stored undiluted. Avoid repeated freezing and thawing as this may denature the antibody. Should this product contain a precipitate we recommend microcentrifugation before use. - Guarantee
- 12 months from date of despatch
More Information
Applications of EGF R antibody
| Application Name | Verified | Min Dilution | Max Dilution |
|---|---|---|---|
| ELISA | |||
| Western Blotting | 1/1000 |
Where this product has not been tested for use in a particular technique this does not necessarily exclude its use in such procedures. Suggested working dilutions are given as a guide only. It is recommended that the user titrates the product for use in their own system using appropriate negative/positive controls.
Copyright © 2020 Bio-Rad Antibodies (formerly AbD Serotec)
Secondary Antibodies Available
Product Specific References
Further Reading
-
Ciardiello, F. & Tortora, G. (2008) EGFR antagonists in cancer treatment.
N Engl J Med. 358 (11): 1160-74. -
Prenzel, N. et al. (2001) The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification.
Endocr Relat Cancer. 8 (1): 11-31.
